Biotransformation of cinobufagin by cell suspension cultures of Catharanthus roseus and Platycodon grandiflorum

[1]  W. A. Loughlin.  Biotransformations in organic synthesis , 2000 .

[2]  E. Abourashed,et al.  Microbial models of mammalian metabolism of xenobiotics: An updated review. , 1999, Current medicinal chemistry.

[3]  M. Inoue,et al.  Structure-cytotoxic activity relationship for the toad poison bufadienolides. , 1998, Bioorganic & medicinal chemistry.

[4]  L. Krenn,et al.  Bufadienolides from animal and plant sources. , 1998, Phytochemistry.

[5]  P. Steyn,et al.  Bufadienolides of plant and animal origin. , 1998, Natural product reports.

[6]  H. Yeung,et al.  Simultaneous Determination of Bufadienolides in the Traditional Chinese Medicine Preparation, Liu‐Shen‐Wan, by Liquid Chromatography * , 1992, The Journal of pharmacy and pharmacology.

[7]  T. Yoshida,et al.  Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. , 1992, Cancer research.

[8]  T. Yoshida,et al.  Deacetylation of cinobufagin by rat liver. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[9]  T. Yoshida,et al.  Metabolism of cinobufagin in rat liver microsomes. Identification of epimerized and deacetylated metabolites by liquid chromatography/mass spectrometry. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[10]  T. Yoshida,et al.  Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. , 1991, Biochemical and biophysical research communications.

[11]  K. Lee,et al.  Antitumor agents, 110. Bryophyllin B, a novel potent cytotoxic bufadienolide from Bryophyllum pinnatum. , 1989, Journal of natural products.

[12]  M. Kawakami,et al.  Metabolism and pharmacokinetics of cinobufagin. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.